ResearcherAnhui Medical UniversityActive in the last 2 years

Chuifang Kong

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5112979159. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation. Co-author DOI 10.1038/s42003-026-10009-1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pengwei Cao · 1 shared paper, 2026 · strength 0.23
- Paper Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation. DOI 10.1038/s42003-026-10009-1 ↗
Daoxiang Zhang · 1 shared paper, 2026 · strength 0.23
- Paper Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation. DOI 10.1038/s42003-026-10009-1 ↗
Mengjie Lv · 1 shared paper, 2026 · strength 0.23
- Paper Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation. DOI 10.1038/s42003-026-10009-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.